Global Intravenous Solutions Market to Reach USD 23.3 Billion by 2033, Augmented by Investments to Expand Production Capacities

November 07, 2024 | Healthcare

According to the latest report by IMARC Group, titled “Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2025-2033”, the global intravenous solutions market size reached USD 15.6 Billion in 2024. Intravenous (IV) solutions, also known as intravenous fluids, are administered to a patient to provide salt, sugar and water directly into their venous circulation. It is required when an individual is ill, going through an operation or is not in the condition to eat or drink. IV solutions and electrolytes are mainly used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and fluids have become an integral part of modern therapy.

Global Intravenous Solutions Market Trends:

Over the past few years, the prevalence of hectic work schedules and unhealthy lifestyles has increased across the globe. The consequent decline in physical activity and proper nutrition has led to a rise in the incidences of chronic diseases, which in turn has boosted the demand for intravenous solutions. Besides, there has been significant growth in the production of IV fluids, particularly in developed countries. For instance, it was reported that due to the shortage of IV saline, the US Food and Drug Administration (FDA) and other market players have been making efforts to mitigate the crisis. In line with this, the US-based marketing and technology company, Merge, partnered with the innovative medical products and services provider, B. Braun Medical, to introduce the ‘Solutions for Life’ omnichannel campaign in May 2019. This initiative is aimed to ensure a consistent supply of IV solutions, approved by the US FDA, across the country. Looking forward, the market value is projected to reach USD 23.3 Billion by 2033, expanding at a CAGR of 4.53% during 2025-2033.

Market Summary:

  • The report has bifurcated the market according to the type into partial parenteral nutrition and total parenteral nutrition. Currently, total parental nutrition is the most preferred type of IV solutions.
  • Based on the nutrients, the market has been segmented as amino acids, carbohydrates, salts and electrolytes, minerals, and vitamins. Amongst these, salts and electrolytes represent the largest segment.
  • On the geographical front, North America is the leading market for intravenous solutions with the majority of the total market share. The growth is led by the rapid expansion of production capacities in the US due to a shortage of IV fluids. Other major regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been examined with some of the key players being Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols S.A., and Otsuka Pharmaceutical Co., Ltd.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units  Billion USD
Segment Coverage Type, Nutrients, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Intravenous Solutions Market to Reach USD 23.3 Billion by 2033, Augmented by Investments to Expand Production Capacities
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials